Literature DB >> 20485791

A paramagnetic chemical exchange-based MRI probe metabolized by cathepsin D: design, synthesis and cellular uptake studies.

Mojmír Suchý1, Robert Ta, Alex X Li, Filip Wojciechowski, Stephen H Pasternak, Robert Bartha, Robert H E Hudson.   

Abstract

Overexpression of the aspartyl protease cathepsin D is associated with certain cancers and Alzheimer's disease; thus, it is a potentially useful imaging biomarker for disease. A dual fluorescence/MRI probe for the potential detection of localized cathepsin D activity has been synthesized. The probe design includes both MRI and optical reporter groups connected to a cell penetrating peptide by a cathepsin D cleavable sequence. This design results in the selective intracellular deposition (determined fluorimetrically) of the MRI and optical reporter groups in the presence of overexpressed cathepsin D. The probe also provided clearly detectable in vitro MRI contrast by the mechanism of paramagnetic chemical exchange effects (OPARACHEE).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20485791     DOI: 10.1039/b926639a

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  15 in total

1.  QUESPOWR MRI: QUantification of Exchange as a function of Saturation Power On the Water Resonance.

Authors:  Edward A Randtke; Mark D Pagel; Julio Cárdenas-Rodríguez
Journal:  J Magn Reson       Date:  2016-07-01       Impact factor: 2.229

2.  Monitoring enzyme activity using a diamagnetic chemical exchange saturation transfer magnetic resonance imaging contrast agent.

Authors:  Guanshu Liu; Yajie Liang; Amnon Bar-Shir; Kannie W Y Chan; Chulani S Galpoththawela; Segun M Bernard; Terence Tse; Nirbhay N Yadav; Piotr Walczak; Michael T McMahon; Jeff W M Bulte; Peter C M van Zijl; Assaf A Gilad
Journal:  J Am Chem Soc       Date:  2011-09-23       Impact factor: 15.419

3.  A CatalyCEST MRI Contrast Agent that Can Simultaneously Detect Two Enzyme Activities.

Authors:  Gabriela Fernández-Cuervo; Sanhita Sinharay; Mark D Pagel
Journal:  Chembiochem       Date:  2016-02-03       Impact factor: 3.164

Review 4.  Molecular imaging of macrophage protease activity in cardiovascular inflammation in vivo.

Authors:  T Quillard; K Croce; F A Jaffer; R Weissleder; P Libby
Journal:  Thromb Haemost       Date:  2011-01-12       Impact factor: 5.249

5.  A nano-sized PARACEST-fluorescence imaging contrast agent facilitates and validates in vivo CEST MRI detection of glioma.

Authors:  Meser M Ali; Mohammed Pi Bhuiyan; Branislava Janic; Nadimpalli Rs Varma; Tom Mikkelsen; James R Ewing; Robert A Knight; Mark D Pagel; Ali S Arbab
Journal:  Nanomedicine (Lond)       Date:  2012-08-14       Impact factor: 5.307

Review 6.  A review of responsive MRI contrast agents: 2005-2014.

Authors:  Dina V Hingorani; Adam S Bernstein; Mark D Pagel
Journal:  Contrast Media Mol Imaging       Date:  2014-10-29       Impact factor: 3.161

Review 7.  Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers.

Authors:  Jessica Wahsner; Eric M Gale; Aurora Rodríguez-Rodríguez; Peter Caravan
Journal:  Chem Rev       Date:  2018-10-16       Impact factor: 60.622

Review 8.  Detecting enzyme activities with exogenous MRI contrast agents.

Authors:  Dina V Hingorani; Byunghee Yoo; Adam S Bernstein; Mark D Pagel
Journal:  Chemistry       Date:  2014-07-02       Impact factor: 5.236

9.  A single diamagnetic catalyCEST MRI contrast agent that detects cathepsin B enzyme activity by using a ratio of two CEST signals.

Authors:  Dina V Hingorani; Luis A Montano; Edward A Randtke; Yeon Sun Lee; Julio Cárdenas-Rodríguez; Mark D Pagel
Journal:  Contrast Media Mol Imaging       Date:  2015-12-03       Impact factor: 3.161

10.  Noninvasive detection of enzyme activity in tumor models of human ovarian cancer using catalyCEST MRI.

Authors:  Sanhita Sinharay; Edward A Randtke; Kyle M Jones; Christine M Howison; Setsuko K Chambers; Hisataka Kobayashi; Mark D Pagel
Journal:  Magn Reson Med       Date:  2016-05-25       Impact factor: 4.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.